We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Greiner Bio-One

The Preanalytics division develops, manufactures and distributes venous blood collection devices for hospitals, labor... read more Featured Products: More products

Download Mobile App





Greiner Bio-One Presents Complete Concept of Digitalized Sample Collection Process

By LabMedica International staff writers
Posted on 23 May 2023
Print article
Image: Tracie software sets new standards in the diagnostic sampling process (Photo courtesy of Tracie)
Image: Tracie software sets new standards in the diagnostic sampling process (Photo courtesy of Tracie)

Greiner Bio-One (Monroe, NC, USA) is collaborating with Tracie Healthcare Solutions (Munich, Germany) to jointly present a complete concept of a digitalized sample collection process at EuroMedLab Rome 2023.

Tracie, an innovative digital healthcare company, provides full support for the sample collection process to eliminate errors and ensure the best possible diagnosis for patients. Through the implementation of Tracie's software, the entire sample collection process is digitized, eliminating the need for manual steps and enabling clear patient identification. This not only enhances patient safety and simplifies day-to-day operations but also improves the overall quality of medical care.

Tracie's aim is to establish an error-free sample collection process for preanalytics, offering valuable support to healthcare professionals in their daily work. The preanalytic process with Tracie involves digital patient identification, allowing healthcare professionals to scan a patient's wristband for quick and accurate identification while simultaneously accessing their extensive data set within the system. Tracie incorporates safety mechanisms, ensuring an error-free match between patient and sample through a simple scan and indicating any missing samples in the system.

During sample collection, Tracie provides supportive notes on samples, patients, and procedures, as well as handles the documentation of the process. Acting as an intermediary between the station and the lab, Tracie collects essential information, such as timestamps, and forwards it to the lab for consideration during analysis. Healthcare professionals can easily manage their workload by accessing a list of upcoming tasks on a tablet or laptop, allowing them to organize their workflow efficiently using a range of features.

In addition, Greiner Bio-One and Tracie are hosting a workshop on the topic of “Digitalizing your lab – how to and why?” In the workshop, eminent speakers will provide insights into the goals that laboratories are pursuing through digitalization and how they are navigating the change process. The workshop is set up in three different parts, addressing the topic of digitization from different perspectives – the hospital lab perspective, private lab perspective, and experience sharing perspective.

Related Links:
Greiner Bio-One
Tracie Healthcare Solutions 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Hemoglobin Testing System
VARIANTnbs

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Protein ‘signatures’ obtained via a blood sample can be used to predict the onset of 67 diseases (Photo courtesy of Queen Mary University of London)

Protein Signatures in Blood Can Predict Risk of Developing More Than 60 Diseases

Measuring specific proteins to diagnose conditions like heart attacks, where troponin is tested, is a well-established clinical practice. Now, new research highlights the broader potential of protein measurements... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Microbiology

view channel
Image: The Simplexa C. auris direct kit is a real-time polymerase chain reaction assay run on the LIAISON MDX instrument (Photo courtesy of Diasorin)

Novel Molecular Test to Help Prevent and Control Multi Drug-Resistant Fungal Pathogen in Healthcare Settings

Candida auris (C. auris) is a rapidly emerging multi drug-resistant fungal pathogen that is commonly found in healthcare environments, where it presents a challenge due to its ability to asymptomatically... Read more

Pathology

view channel
Image: The tool can improve precision oncology by accurately predicting molecular subtypes and therapy responses (Photo courtesy of Shutterstock)

Computational Tool Integrates Transcriptomic Data for Improved Breast Cancer Diagnosis and Treatment

Breast cancer is the most commonly diagnosed cancer globally, presenting in various subtypes that require precise identification for effective, personalized treatment. Traditionally, cancer subtyping has... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.